Cell Signaling Technology

DMF (Dimethylformamide)

#12767 · $41

84
Citing papers
2.5k
Combined citations
Supplier page Find this product

Research areas

Nerve injury and regeneration15Neurogenesis and neuroplasticity mechanisms14Parkinson's Disease Mechanisms and Treatments10Neuroinflammation and Neurodegeneration Mechanisms7Neuroscience and Neuropharmacology Research6Autophagy in Disease and Therapy5Neuropeptides and Animal Physiology4Helicobacter pylori-related gastroenterology studies4

Papers citing this product

1
Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines
Nature Communications·2012·396 cit.·DOI
2
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
JCI Insight·2021·136 cit.·DOI
3
Aging and a Peripheral Immune Challenge Interact to Reduce Mature Brain-Derived Neurotrophic Factor and Activation of TrkB, PLCγ1, and ERK in Hippocampal Synaptoneurosomes
Journal of Neuroscience·2011·120 cit.·DOI
4
Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity
Acta Neuropathologica·2019·94 cit.·DOI
5
Positive Feedback Regulation between γ-Aminobutyric Acid Type A (GABAA) Receptor Signaling and Brain-derived Neurotrophic Factor (BDNF) Release in Developing Neurons
Journal of Biological Chemistry·2011·90 cit.·DOI
6
Tetramethylpyrazine nitrone activates the BDNF/Akt/CREB pathway to promote post‐ischaemic neuroregeneration and recovery of neurological functions in rats
British Journal of Pharmacology·2017·89 cit.·DOI
7
Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy
Cell Death and Disease·2020·77 cit.·DOI
8
Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress
The International Journal of Neuropsychopharmacology·2011·75 cit.·DOI
9
MicroRNA-185 Targets SOCS3 to Inhibit Beta-Cell Dysfunction in Diabetes
PLoS ONE·2015·74 cit.·DOI
10
<scp>PIK</scp>3<scp>CD</scp> induces cell growth and invasion by activating <scp>AKT</scp>/<scp>GSK</scp>‐3β/β‐catenin signaling in colorectal cancer
Cancer Science·2019·73 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.